tiprankstipranks
Diagonal Bio AB (DE:9F1)
FRANKFURT:9F1
Germany Market

Diagonal Bio AB (9F1) Income Statement

0 Followers

Diagonal Bio AB Income Statement

Last quarter (Q4 2022), Diagonal Bio AB's total revenue was kr0.00, a decrease of -100.00% from the same quarter last year. In Q4, Diagonal Bio AB's net income was kr-4.19M. See Diagonal Bio AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20
Total Revenue
kr 204.00Kkr 203.00Kkr 407.00Kkr 20.00K
Cost of Revenue
kr -1.85Mkr -1.85Mkr 492.00Kkr 72.00K
Gross Profit
kr 2.06Mkr 2.05Mkr -85.00Kkr -52.00K
Operating Expense
kr 17.22Mkr 17.22Mkr 11.58Mkr 531.00K
Operating Income
kr -15.16Mkr -15.16Mkr -11.66Mkr -583.00K
Net Non Operating Interest Income Expense
kr -1.00Mkr -1.00Mkr 0.00kr 0.00
Other Income Expense
----
Pretax Income
kr -16.16Mkr -16.16Mkr -11.66Mkr -583.00K
Tax Provision
-kr 0.00kr 0.00kr 0.00
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
kr -16.16Mkr -16.16Mkr -11.66Mkr -583.00K
Basic EPS
kr -0.90--kr -0.06
Diluted EPS
kr -0.90--kr -0.06
Basic Average Shares
kr 18.30M--kr 9.15M
Diluted Average Shares
kr 18.30M--kr 9.15M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
kr 15.37Mkr 15.37Mkr 12.07Mkr 603.00K
Net Income From Continuing And Discontinued Operation
kr -16.16Mkr -16.16Mkr -11.66Mkr -583.00K
Normalized Income
kr -16.16Mkr -16.16Mkr -11.66Mkr -583.00K
Interest Expense
kr 1.00Mkr 1.00Mkr 0.00kr 0.00
EBIT
kr -15.16Mkr -15.16Mkr -11.66Mkr -583.00K
EBITDA
kr -15.16Mkr -15.16Mkr -11.66Mkr -583.00K
Currency in SEK

Diagonal Bio AB Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis